165 related articles for article (PubMed ID: 25104560)
1. Region- and age-dependent reductions of hippocampal long-term potentiation and NMDA to AMPA ratio in a genetic model of Alzheimer's disease.
Tozzi A; Sclip A; Tantucci M; de Iure A; Ghiglieri V; Costa C; Di Filippo M; Borsello T; Calabresi P
Neurobiol Aging; 2015 Jan; 36(1):123-33. PubMed ID: 25104560
[TBL] [Abstract][Full Text] [Related]
2. NMDA receptor-dependent signaling pathways that underlie amyloid beta-protein disruption of LTP in the hippocampus.
Yamin G
J Neurosci Res; 2009 Jun; 87(8):1729-36. PubMed ID: 19170166
[TBL] [Abstract][Full Text] [Related]
3. Non-fibrillar beta-amyloid abates spike-timing-dependent synaptic potentiation at excitatory synapses in layer 2/3 of the neocortex by targeting postsynaptic AMPA receptors.
Shemer I; Holmgren C; Min R; Fülöp L; Zilberter M; Sousa KM; Farkas T; Härtig W; Penke B; Burnashev N; Tanila H; Zilberter Y; Harkany T
Eur J Neurosci; 2006 Apr; 23(8):2035-47. PubMed ID: 16630051
[TBL] [Abstract][Full Text] [Related]
4. Oral treatment with a gamma-secretase inhibitor improves long-term potentiation in a mouse model of Alzheimer's disease.
Townsend M; Qu Y; Gray A; Wu Z; Seto T; Hutton M; Shearman MS; Middleton RE
J Pharmacol Exp Ther; 2010 Apr; 333(1):110-9. PubMed ID: 20056779
[TBL] [Abstract][Full Text] [Related]
5. Alzheimer amyloid beta-peptide inhibits the late phase of long-term potentiation through calcineurin-dependent mechanisms in the hippocampal dentate gyrus.
Chen QS; Wei WZ; Shimahara T; Xie CW
Neurobiol Learn Mem; 2002 May; 77(3):354-71. PubMed ID: 11991763
[TBL] [Abstract][Full Text] [Related]
6. Age-related impairment of synaptic transmission but normal long-term potentiation in transgenic mice that overexpress the human APP695SWE mutant form of amyloid precursor protein.
Fitzjohn SM; Morton RA; Kuenzi F; Rosahl TW; Shearman M; Lewis H; Smith D; Reynolds DS; Davies CH; Collingridge GL; Seabrook GR
J Neurosci; 2001 Jul; 21(13):4691-8. PubMed ID: 11425896
[TBL] [Abstract][Full Text] [Related]
7. Age-related synaptic dysfunction in Tg2576 mice starts as a failure in early long-term potentiation which develops into a full abolishment of late long-term potentiation.
Fernández-Fernández D; Dorner-Ciossek C; Kroker KS; Rosenbrock H
J Neurosci Res; 2016 Mar; 94(3):266-81. PubMed ID: 26629777
[TBL] [Abstract][Full Text] [Related]
8. Long-term potentiation is increased in the CA1 area of the hippocampus of APP(swe/ind) CRND8 mice.
Jolas T; Zhang XS; Zhang Q; Wong G; Del Vecchio R; Gold L; Priestley T
Neurobiol Dis; 2002 Dec; 11(3):394-409. PubMed ID: 12586549
[TBL] [Abstract][Full Text] [Related]
9. Defective synaptic transmission and structure in the dentate gyrus and selective fear memory impairment in the Rsk2 mutant mouse model of Coffin-Lowry syndrome.
Morice E; Farley S; Poirier R; Dallerac G; Chagneau C; Pannetier S; Hanauer A; Davis S; Vaillend C; Laroche S
Neurobiol Dis; 2013 Oct; 58():156-68. PubMed ID: 23742761
[TBL] [Abstract][Full Text] [Related]
10. Synaptic dysfunction in hippocampus of transgenic mouse models of Alzheimer's disease: a multi-electrode array study.
Chong SA; Benilova I; Shaban H; De Strooper B; Devijver H; Moechars D; Eberle W; Bartic C; Van Leuven F; Callewaert G
Neurobiol Dis; 2011 Dec; 44(3):284-91. PubMed ID: 21807097
[TBL] [Abstract][Full Text] [Related]
11. AMPA silencing is a prerequisite for developmental long-term potentiation in the hippocampal CA1 region.
Abrahamsson T; Gustafsson B; Hanse E
J Neurophysiol; 2008 Nov; 100(5):2605-14. PubMed ID: 18799599
[TBL] [Abstract][Full Text] [Related]
12. IVIG immunotherapy protects against synaptic dysfunction in Alzheimer's disease through complement anaphylatoxin C5a-mediated AMPA-CREB-C/EBP signaling pathway.
Gong B; Pan Y; Zhao W; Knable L; Vempati P; Begum S; Ho L; Wang J; Yemul S; Barnum S; Bilski A; Gong BY; Pasinetti GM
Mol Immunol; 2013 Dec; 56(4):619-29. PubMed ID: 23911420
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal testing of hippocampal plasticity reveals the onset and maintenance of endogenous human Aß-induced synaptic dysfunction in individual freely behaving pre-plaque transgenic rats: rapid reversal by anti-Aß agents.
Qi Y; Klyubin I; Harney SC; Hu N; Cullen WK; Grant MK; Steffen J; Wilson EN; Do Carmo S; Remy S; Fuhrmann M; Ashe KH; Cuello AC; Rowan MJ
Acta Neuropathol Commun; 2014 Dec; 2():175. PubMed ID: 25540024
[TBL] [Abstract][Full Text] [Related]
14. Endogenous secreted amyloid precursor protein-alpha regulates hippocampal NMDA receptor function, long-term potentiation and spatial memory.
Taylor CJ; Ireland DR; Ballagh I; Bourne K; Marechal NM; Turner PR; Bilkey DK; Tate WP; Abraham WC
Neurobiol Dis; 2008 Aug; 31(2):250-60. PubMed ID: 18585048
[TBL] [Abstract][Full Text] [Related]
15. Pregnenolone sulfate enhances long-term potentiation in CA1 in rat hippocampus slices through the modulation of N-methyl-D-aspartate receptors.
Sliwinski A; Monnet FP; Schumacher M; Morin-Surun MP
J Neurosci Res; 2004 Dec; 78(5):691-701. PubMed ID: 15505794
[TBL] [Abstract][Full Text] [Related]
16. Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease.
McClean PL; Hölscher C
Neuropharmacology; 2014 Jan; 76 Pt A():57-67. PubMed ID: 23973293
[TBL] [Abstract][Full Text] [Related]
17. Impaired learning and LTP in mice expressing the carboxy terminus of the Alzheimer amyloid precursor protein.
Nalbantoglu J; Tirado-Santiago G; Lahsaïni A; Poirier J; Goncalves O; Verge G; Momoli F; Welner SA; Massicotte G; Julien JP; Shapiro ML
Nature; 1997 May; 387(6632):500-5. PubMed ID: 9168112
[TBL] [Abstract][Full Text] [Related]
18. Ca2+/calmodulin-dependent protein kinase II and protein kinase C activities mediate extracellular glucose-regulated hippocampal synaptic efficacy.
Moriguchi S; Oomura Y; Shioda N; Han F; Hori N; Aou S; Fukunaga K
Mol Cell Neurosci; 2011 Jan; 46(1):101-7. PubMed ID: 20807573
[TBL] [Abstract][Full Text] [Related]
19. L-type Ca2+ currents at CA1 synapses, but not CA3 or dentate granule neuron synapses, are increased in 3xTgAD mice in an age-dependent manner.
Wang Y; Mattson MP
Neurobiol Aging; 2014 Jan; 35(1):88-95. PubMed ID: 23932880
[TBL] [Abstract][Full Text] [Related]
20. Smad3 deficiency inhibits dentate gyrus LTP by enhancing GABAA neurotransmission.
Muñoz MD; Antolín-Vallespín M; Tapia-González S; Sánchez-Capelo A
J Neurochem; 2016 Apr; 137(2):190-9. PubMed ID: 26826552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
